Epidermal Growth Factor Receptor Mutations
Author:
Funder
Merck
Takeda
Helsinn
Bristol Myers Squibb
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Surgery
Reference66 articles.
1. Expert opinion on therapeutic targets targeting the EGFR signaling pathway in cancer therapy targeting the EGFR signaling pathway in cancer therapy;Seshacharyulu;Expert Opin Ther Targets,2017
2. Evaluation of EGFR abnormalities in patients with pulmonary adenocarcinoma: the need to test neoplasms with more than one method;Gupta;Mod Pathol,2009
3. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with NSCLC: a randomized trial;Kris;J Am Med Assoc,2003
4. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced NSCLC (The IDEAL1 Trial) [corrected];Fukuoka;J Clin Oncol,2003
5. Activating mutations in the epidermal growth factor receptor underlying responsiveness of NSCLC to gefitinib;Lynch;N Engl J Med,2004
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The predictive value of [18F]FDG PET/CT radiomics combined with clinical features for EGFR mutation status in different clinical staging of lung adenocarcinoma;EJNMMI Research;2023-04-04
2. Oncology: Way Forward from Clinical and Molecular Diagnosis to Treatment;Oncology: Genomics, Precision Medicine and Therapeutic Targets;2023
3. The prognostic relationship of 18F-FDG PET/CT metabolic and volumetric parameters in metastatic ALK + NSCLC;Nuclear Medicine Communications;2022-10-19
4. Design, Synthesis and Antitumor Activities of Novel Quinazolinone Derivatives as Potential EGFR Inhibitors;Chemical and Pharmaceutical Bulletin;2022-09-01
5. Cost-Effectiveness of Parallel Versus Sequential Testing of Genetic Aberrations for Stage IV Non–Small-Cell Lung Cancer in the Netherlands;JCO Precision Oncology;2022-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3